Galapagos N.V. (OP:GLPGF)

34.00 UNCHANGED

Last Price Updated: 12:49 PM EST, Feb 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Galapagos N.V.

Galapagos' Filgotinib Shows Clinical Benefit In Ulcerative Colitis Non-Responding Patients ↗

October 05, 2021

Galapagos NV (NASDAQ: GLPG) announced results of two post-hoc analyses from the SELECTION and SELECTION LTE studies of filgotinib for active ulcerative colitis (UC...

Via Benzinga

Galapagos Assumes Responsibility Of Late-Stage Filgotinib Trial In Crohn's Disease ↗

October 04, 2021

Galapagos NV (NASDAQ: GLPG) has randomized the last patient into the DIVERSITY Phase 3 study of filgotinib in the induction and maintenance of remission in...

Via Benzinga

Galapagos' Long-Serving CEO Onno Van De Stolpe To Exit After R&D Setbacks ↗

August 31, 2021

After 22 years at the helm of Galapagos NV (NASDAQ: GLPG), chief executive Onno van de Stolpe has decided it is time to retire and hand the reins to new...

Via Benzinga

Galapagos' Another Psoriasis Candidate Shows Efficacy, Safety Profile In Mid-Stage Study ↗

July 15, 2021

Galapagos NV (NASDAQ: GLPG) reported topline results with tyrosine kinase 2 (TYK2) inhibitor GLPG3667 in a Phase 1b study in psoriasis patients. At Week 4, four...

Via Benzinga

Galapagos Shares Drop As SIK Inhibitor Fails To Show Positive Outcomes In Ulcerative Colitis, Rheumatoid Arthritis Patients ↗

July 15, 2021

Galapagos NV (NASDAQ: GLPG) reports topline results from three studies evaluating GLPG3970, a SIK inhibitor, in psoriasis, ulcerative colitis (UC), and rheumatoid...

Via Benzinga

Galapagos Drops Early Metabolic & Osteoarthritis Programs, Reorganizes R&D Efforts ↗

May 07, 2021

Galapagos NV (NASDAQ: GLPG) is chopping its pipeline to conserve cash while its business development team pursues a mission to find a “transformative...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Galapagos N.V. (OP:GLPGF)

All News about Galapagos N.V.

Starting at $3.75/week.

Subscribe Today